In this section: Health

Patient Education · Women’s Health

Postpartum depression and anxiety: symptoms, newer treatment, and when to get help

Recognize postpartum depression, anxiety, OCD, bipolar symptoms, and psychosis. Learn about therapy, medicines, zuranolone, and urgent help.

Written and medically reviewed by Kanwar Partap Singh Gill, MD, family medicine, FresnoMedically reviewed Sources checked 1 November 2026

Get help now

Call 911 for chest pain or pressure, trouble breathing, fainting, signs of a stroke, heavy bleeding with dizziness, or any immediate risk of serious harm. For a mental-health crisis, call or text 988.

During pregnancy and for a year after birth, seek care immediately for a severe or worsening headache, vision changes, chest pain, trouble breathing, heavy bleeding, fainting or a fever of 100.4°F (38°C) or higher, and say that you are pregnant or recently gave birth.

Pregnancy and postpartum emotional support: 1-833-TLC-MAMA (1-833-852-6262), free and confidential. It does not replace emergency care.

The short answer: If your mood, worry, thoughts, or sleep are interfering with life during pregnancy or after birth, tell a clinician. These conditions are treatable. Help does not depend on looking visibly ill, having an uncomplicated delivery, or being certain of the diagnosis. PM11 PM20

Get emergency help now if there is an immediate risk of harm, severe confusion, hallucinations, fixed unusual beliefs, or behavior suggesting loss of contact with reality. Call 911 or go to emergency care. If possible, a trusted adult should stay with the person and ensure the infant is safely cared for while help is arranged. For suicidal distress, call or text 988; immediate danger still requires 911. PM11

Which symptoms deserve attention?

Depression may appear as sadness, loss of interest, guilt, irritability, numbness, or feeling unable to cope. Anxiety may involve relentless worry, panic, repeated checking, or being unable to settle even when the baby is safe. Difficulty bonding can occur and is a reason to ask for support. Mild, brief “baby blues” generally improve within two weeks. Severe symptoms or symptoms that continue beyond that point need evaluation; the two-week marker is not a waiting requirement. PM47 PM12

Screening questionnaires such as the EPDS or PHQ-9 can help start the conversation and track recovery, but a score is not a diagnosis. A clinician should assess your symptoms, functioning, safety, sleep, past episodes, medical conditions, substances, and medicines. ACOG recommends screening for depression and anxiety at the first prenatal visit, later in pregnancy, and postpartum. A positive result needs a follow-up plan. PM12

Intrusive thoughts, OCD, and psychosis are not the same

Some people have frightening thoughts or images they do not want and repeatedly try to prevent. OCD can involve unwanted thoughts and rituals or checking that consume time and cause distress. Treatment can include a form of cognitive behavioral therapy called exposure and response prevention, with medication when appropriate. Tell the clinician exactly what happens, whether the thought feels unwanted, and whether you fear or intend to act on it. PM23

Unwanted thoughts do not automatically mean someone intends harm. They still deserve prompt assessment, particularly if they are new, worsening, or make infant care difficult. In contrast, hallucinations, delusions, severe disorganization, or inability to recognize what is real may signal psychosis. A website cannot safely make that distinction for you. Seek emergency help if you are unsure about immediate safety. PM23 PM65

Why the clinician asks about bipolar disorder

Periods of very little sleep with unusual energy, racing thoughts, extreme irritability, impulsive behavior, or feeling unusually powerful may suggest mania or hypomania. Tell the clinician about previous episodes and family history, even if you are currently depressed. Antidepressants alone can worsen the course of bipolar disorder in some patients, which is why ACOG calls for bipolar screening before starting medication for depression or anxiety when screening has not already occurred. PM12 PM22

Treatment has several parts

Psychotherapy can help with depression and anxiety during and after pregnancy. Cognitive behavioral therapy works on patterns of thought and behavior; interpersonal therapy addresses relationships, support, and major life transitions. Medication may be appropriate depending on severity, prior response, preferences, pregnancy or feeding status, and other conditions. Ask what improvement should look like, when to reassess, and what to do if symptoms worsen. PM11 PM48

Pregnancy or breastfeeding alone is not a reason to withhold every psychiatric medicine or abruptly stop effective treatment. The discussion must compare medication risks with the risks of untreated illness and relapse. A specialist may help when symptoms are severe, bipolar disorder is suspected, treatment is not working, or medication decisions are complex. Practical support and sleep protection can accompany treatment, but they do not replace assessment of significant illness. PM48

What is new about zuranolone?

Zuranolone, sold as Zurzuvae, is an oral treatment FDA-approved for postpartum depression in adults. Its prescribed course lasts 14 days. The label allows use alone or alongside an oral antidepressant. It is not a medicine to start from an online symptom score. PM14

ACOG's updated guidance, published in the January 2026 issue of Obstetrics & Gynecology, recommends considering it during the first 12 months after delivery for severe depression that began in the third trimester or within four weeks after birth. That recommendation reflects the studied population; the FDA indication itself does not contain the same severity qualifier. Trials showed benefit compared with placebo. They do not establish that zuranolone is better than an SSRI or psychotherapy for every patient, and follow-up remains necessary after the short course ends. ACOG does not recommend simply repeating a course when symptoms persist or return. PM13

The April 2026 prescribing information includes a boxed warning about impaired driving. Patients must avoid driving and other hazardous activities for at least 12 hours after each dose, and they may not accurately judge their own impairment. Sedation, confusion, interacting medicines, alcohol, kidney or liver issues, pregnancy prevention, and safe infant-care arrangements require review. Effective contraception is advised during treatment and for one week afterward. Milk levels appear low, but infant-effect data are lacking; feeding decisions need an individualized discussion. PM14

A correction to older information: Brexanolone, formerly sold as the intravenous treatment Zulresso, should not be listed as a routinely available U.S. option. Commercial availability ended January 1, 2025. FDA withdrew approval effective April 14, 2025, following the manufacturer's request. This withdrawal should not be described as proof of a newly discovered safety problem. PM15

How to ask for help today

You can say: “I gave birth recently, and I am not feeling like myself. My sleep, mood, or thoughts are making daily life difficult. I need help assessing these changes and making a treatment plan.” Tell the office if there are safety concerns so it can direct you appropriately.

For support and help finding care, call or text the National Maternal Mental Health Hotline, 1-833-852-6262 (1-833-TLC-MAMA). It is free and available 24/7. It is a support service, not a replacement for 988 or 911 during a crisis. PM16

Ask the treating team:

  • What diagnosis are we considering, and have bipolar disorder and medical causes been assessed?
  • Which treatment fits my symptoms and feeding plan?
  • If zuranolone is considered, who helps with access, monitoring, transport, and infant care?
  • When will you contact me again, and whom do I call if I worsen?
  • What should my family or support person watch for?

Find care in Fresno

The Fresno care directory explains which kind of clinician fits which problem and lists official contacts; the visit-preparation guide helps you get the most from the appointment. For appointments, results, prescriptions or referrals, use your own clinic’s official telephone line or secure patient portal.

Sources

Source links checked 1 November 2026. Medically reviewed and approved for publication by Kanwar Partap Singh Gill, MD, on 1 November 2026.

  1. PM11 NIMH: Perinatal Depression.
  2. PM12 ACOG: Patient Screening—Perinatal Mental Health.
  3. PM13 ACOG Clinical Practice Update: Zuranolone and Brexanolone for the Treatment of Postpartum Depression. Source date: 2026-01 issue; online 2025-10-09.
  4. PM14 DailyMed: ZURZUVAE (zuranolone) Prescribing Information. Source date: Revised 2026-04.
  5. PM15 FDA: Withdrawal of ZULRESSO approval, Federal Register 90 FR 12162–12163. Source date: Published 2025-03-14; effective 2025-04-14.
  6. PM16 HRSA: National Maternal Mental Health Hotline FAQ.
  7. PM20 NIMH: Women and Mental Health.
  8. PM22 NIMH: Bipolar Disorder.
  9. PM23 NIMH: Obsessive-Compulsive Disorder—When Unwanted Thoughts or Repetitive Behaviors Take Over.
  10. PM47 ACOG: Postpartum Depression.
  11. PM48 ACOG: Assessment and Treatment of Perinatal Mental Health Conditions.
  12. PM65 NIMH: Understanding Psychosis.
About this information. This guide provides general health information. Your own care depends on your symptoms, medical history, medicines, and examination. For appointments, test results, prescriptions, or referrals, contact your care team through its official channels. For an emergency, call 911.

← All women’s health guides · Patient education

Approved for publication by Kanwar Partap Singh Gill, MD · 1 November 2026. Medically reviewed .

Search KPSGill.com

Search the full publication — patient guides, policy, investigations, enforcement records and research.